COMMUNIQUÉS West-GlobeNewswire

B. Braun’s Innovative Compounding System Installed at Texas Children’s Hospital

10/12/2018 - 15:02

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. successfully installed its new and innovative macro and micro APEX ® Compounding System at Texas Children’s Hospital in Houston, Texas. The [...]

Financial calendar for Zealand Pharma in 2019

10/12/2018 - 15:00

Company announcement – No. 30/2018 Financial calendar for Zealand Pharma in 2019 Copenhagen, December 10, 2018 – Zealand Pharma A/S (“ZEAL”) announces the following dates for the company's planned financial reporting in [...]

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

10/12/2018 - 15:00

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE [...]

Editas Medicine Names Cynthia Collins to Board of Directors

10/12/2018 - 15:00

CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it has appointed Cynthia Collins to its Board of Directors. Ms. Collins is [...]

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease

10/12/2018 - 15:00

Phase 1b study includes Parkinson’s disease patients with and without a genetic LRRK2 mutation SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical [...]

Advantis Corp.’s Pet Division Making Progress Toward Debut

10/12/2018 - 15:00

NEWPORT BEACH, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it has entered into negotiations with potential manufacturers of its products for the [...]

MPX Awarded Four Conditional Retail Dispensary Licenses in Nevada

10/12/2018 - 14:41

TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC (“ GreenMart NLV ”), a subsidiary of MPX, has been awarded [...]

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

10/12/2018 - 14:35

December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston, MA SVP R&D leading workshop on Financial Planning and Commercial Development SVP R&D to present A Translational R& [...]

Novo Nordisk A/S - Share repurchase programme

10/12/2018 - 14:31

Bagsværd, Denmark, 10 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

10/12/2018 - 14:31

Press release December 10, 2018 Appeal on Enzymatica's cold spray in Germany overruled Enzymatica has been informed that the Frankfurt Higher Regional Court - OLG (Oberlandesgericht) has overruled the appeal on a [...]

Agritek Holdings, Inc. Announces Resignation of CEO, Names New Interim CEO, With Company To Bring On New Advisory Board And Management Consultants Specializing In Cannabis Sector

10/12/2018 - 14:30

LOS ANGELES, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]

Eve & Co Receives Expanded Health Canada Licences

10/12/2018 - 14:25

TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that as of December 7, 2018, Health Canada authorized Natural [...]

Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018

10/12/2018 - 14:08

VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying a booth at the O [...]

Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay

10/12/2018 - 14:01

Thermo Fisher Scientific and Achaogen jointly develop new assay to enable Therapeutic Drug Management SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical [...]

Allscripts to sell its interests in Netsmart

10/12/2018 - 14:01

CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that it has signed a definitive agreement to sell its interests in Netsmart [...]

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

10/12/2018 - 14:01

SANTA BARBARA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on December 5, 2018, the Compensation Committee of [...]

Introducing The Diamond CBD Referral Program Give $25 and Receive $25 by Referring a Friend

10/12/2018 - 14:00

FT LAUDERDALE, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Diamond CBD, Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN ) is pleased to announce the successful introduction to [...]

Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer

10/12/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing engineered Natural Killer (NK) immune cells to fight cancer, today announced that [...]

Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer

10/12/2018 - 14:00

Role to focus on business development as Genocea expands its immunotherapy pipeline and explores additional applications of its ATLAS™ neoantigen identification platform CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE [...]